<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="38559">Cytochrome P450</z:chebi> 1B1 (CYP1B1) <z:chebi fb="2" ids="33699">mRNA</z:chebi> is constitutively expressed in most <z:mpath ids='MPATH_458'>normal</z:mpath> extra-hepatic tissues; however the protein is not detectable in these tissues but is expressed in a wide variety of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>CYP1B1 is responsible for the activation of a number of carcinogens present in tobacco smoke and food </plain></SENT>
<SENT sid="2" pm="."><plain>A surgical model of rat esophageal <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, promoted by gastric or <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenal reflux</z:e> was used to determine CYP1B1 expression in premalignant esophageal tissue </plain></SENT>
<SENT sid="3" pm="."><plain>Immunohistochemistry was performed using a modified amplified <z:chebi fb="0" ids="31624">fluorescein</z:chebi> tyramide protocol </plain></SENT>
<SENT sid="4" pm="."><plain>CYP1B1 was not observed in <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal mucosa, submucosa, or muscularis mucosa </plain></SENT>
<SENT sid="5" pm="."><plain>Animals exposed to gastric reflux developed mild <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Varying degrees of <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> were observed in the <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenal reflux</z:e> group </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> regions of <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> showed moderate or strong CYP1B1 immunoreactivity </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">Duodenal reflux</z:e> induced a small number of premalignant changes: immunoreactivity was absent from the epithelium of squamous <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (0/10), <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (0/7), and majority of dysplastic <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (1/4) </plain></SENT>
<SENT sid="9" pm="."><plain>Moderate or strong immunoreactivity was observed in the majority (7/8) of <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> (<z:mp ids='MP_0004207'>SCCs</z:mp>) in situ </plain></SENT>
<SENT sid="10" pm="."><plain>Immunoreactivity was also observed in the lamina propria and submucosa in association with <z:mp ids='MP_0001845'>inflammation</z:mp>, regardless of the severity of <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>The expression of CYP1B1 in <z:mpath ids='MPATH_134'>hyperplasia</z:mpath>, <z:mp ids='MP_0004207'>SCCs</z:mp> in situ, or in association with <z:mp ids='MP_0001845'>inflammation</z:mp> may increase the production of carcinogenic metabolites, which may promote esophageal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>